GD vs LXRX · P/E 22, rev $52.55B vs rev $21.8M
General Dynamics Corporation (GD) versus Lexicon Pharmaceuticals Inc (LXRX) — a side-by-side from cached financials, not a winner call.
General Dynamics Corporation (GD) is a aerospace & defense company listed on US.
Lexicon Pharmaceuticals Inc (LXRX) is a biotechnology company listed on US.
Latest reported GD revenue for 2025-12-31 was $52.55B. Net income was $4.21B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. GD currently screens at market cap $93.69B and trailing P/E 21.8.
Latest reported LXRX revenue for 2026-06-30 was $21.8M. Net income was -$32.8M. Revenue was up 3.3% from 2026-03-31 to 2026-06-30. LXRX currently screens at market cap $327.2M.
GD currently screens at market cap $93.69B and trailing P/E 21.8. LXRX currently screens at market cap $327.2M.
Not investment advice. Open the GD and LXRX stock pages for the full models.
Not investment advice.